tests that are particularly difficult to interpret; the six donors described in this report are examples.
We believe that we owe it to blood donors to investigate their repeatedly positive results extensively despite the added expense and the time required. The reasons for repeatedly false positive results in screening tests are largely unknown, but this should not mean that the donors are left unsure as to whether or not they have the HIV infection with all the difficulties associated with this diagnosis. Donors' tangible expression of concern for others should, if at all possible, not be allowed to become a source of worry for themselves4; they deserve reassurance whenever possible. fibrosis, splenomegaly and a characteristic appearance of the peripheral blood. Extramedullary haemopoiesis occurs, most commonly in the liver and spleen and less frequently in a variety of other sites.
Bone changes are a characteristic feature of myelofibrosis. Osteosclerosis occurs in 40 to 70%'-3 of patients and the combination of osteosclerosis and splenomegaly is strongly suggestive of myelofibrosis.4 Osteolytic lesions, however, are much less common. Osteolytic lesions are frequently diffuse and may be painful.'2 Reported cases have been predominantly in patients transforming from polycythaemia rubra vera to myelofibrosis and appear to be associated with rapid disease progression.'25 In one report multiple painful osteolytic lesions developed rapidly in a patient diagnosed as having myelofibrosis 18 years earlier. 6 Biopsy specimens taken from such lesions may show a range ofappearances with trilineage hyperplasia, fibrosis or immature cells of the myeloid, and/or megakaryocytic series. 5 There has been a report of osteosclerotic bone lesions being mistaken for metastatic carcinoma in a patient with breast carcinoma, who was subsequently found to have myelofibrosis.7 Another patient with myelofibrosis and breast carcinoma developed multiple osteolytic bone lesions shortly before her death. These lesions were subsequently shown to be due to marrow hyperplasia.5 However, the finding of a single, large, painless osteolytic lesion in a patient known to have both longstanding stable myelofibrosis and a carcinoma appears unusual and initially caused concern regarding the possibility of metastatic bronchial carcinoma. This was discounted after histological examination of the lesion.
The length of time between the diagnosis of myelofibrosis and the finding of the osteolytic lesion (33 years) and the stability of the myelofibrosis are also unusual. Other reported cases have been in patients with progressive disease of shorter duration.
Our patient later died of overwhelming postsplenectomy infection despite complying with postsplenectomy antibiotic prophylaxis. Overwhelming infection in splenectomised patient is a well recognised complication and its occurrence 13 years postoperatively in a patient on prophylactic antibiotics is a salutary reminder of the necessity to treat all postsplenectomy patients who develop infection vigorously with broad spectrum antibiotics including cover for capsulate organisms. 
